Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in osteolytic breast cancer murine modelsVasilios Liapis, Andreas Evdokiou|Cancer Medicine|2016Cited by 30
Targeting Cancer in the Bone with the Hypoxia Activated Pro-Drug EvofosfamideVasilios Liapis|Adelaide Research & Scholarship (AR&S) (University of Adelaide)|2017Cited by 0